{
  "@context": "aku-v2",
  "@type": "genetics",
  "@id": "vasc:vm:cm-avm-syndrome",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:36:00.000Z",
    "updated": "2026-01-07T03:36:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.88,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vascular-malformations",
    "type": "genetic-syndrome",
    "difficulty": "advanced",
    "importance": "specialized"
  },
  "content": {
    "title": "CM-AVM Syndrome",
    "description": "Autosomal dominant disorder with capillary malformations and associated arteriovenous malformations",
    "key_concepts": [
      {"concept": "Genetics", "details": "RASA1 mutations (CM-AVM1) or EPHB4 mutations (CM-AVM2)"},
      {"concept": "CM Features", "details": "Multiple small round/ovoid capillary malformations with pale halos"},
      {"concept": "AVM Risk", "details": "30% develop fast-flow lesions (brain, spine, soft tissue)"},
      {"concept": "Screening", "details": "Consider brain/spine MRI in affected individuals"}
    ],
    "clinical_significance": "Multiple atypical CMs should prompt genetic testing and AVM screening"
  },
  "provenance": {"primary_sources": ["Amyere M et al. Nat Genet 2013"]}
}
